Arterial hypertension in women in the menopausal period;Nadciśnienie tetnicze u kobiet w okresie menopauzy

Przeglad Menopauzalny

Volumn 7, Issue 2, 2008, Pages 96-101

  Stachowiak, Grzegorz ^a   Faflik, Urszula ^b   Zajac, Agnieszka ^a   Stetkiewicz, Tomasz ^a   Pertyński, Tomasz ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Arterial hypertension; Cardiovascular diseases; Contraception; Hormonal therapy; Menopause

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRACEPTIVE AGENT; DESOGESTREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DROSPIRENONE; DROSPIRENONE PLUS ESTRADIOL; ENDOTHELIN 1; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MINERALOCORTICOID ANTAGONIST; PADGEM PROTEIN; PROSTACYCLIN; SEX HORMONE; VASCULAR CELL ADHESION MOLECULE 1;

ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; HORMONAL THERAPY; HUMAN; HYPERTENSION; MENOPAUSE; MORBIDITY; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 44649197684     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Krupa-Wojciechowska B, Zdrojewski T, Pieńkowski R i wsp. Znajomość własnego ciśnienia tetniczego krwi przez dorosłych Polaków. Wyniki reprezentatywnego sondażu wrzesień 1997. Nadciśnienie Tetnicze 1997; 1: 94-100.
2. Suchecka-Rachoń K. Nadciśnienie tetnicze w okresie przed- i pomenopauzalnym. W: Choroby serca u koblet. Światecka G (red.). Via Medica, Gdańsk 2000; 263-81.
3. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health 1988; 786: 676-9.
4. Belanger A, Cupples LA, D'Agostno RB. Means of each examination and inter-examination consistency of specified characteristics: Framingham Heart Study; 30-year follow-up. National Institutes of Health, Public Health Service Washington 1988; 2970-80.
5. Staessen J, Bulpitt C, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8: 393-405.
6. Rywik S. Wybrane problemy z epidemiologii nadciśnienia tetniczego. Nadciśnienie Tetnicze 1998; 7 (supl.): 3-12.
7. Program POL-MONICA Kompleksowa ocena stanu zdrowia ludności Warszawy i jego zmian w latach 1984-1990. Instytut Kardiologii, Warszawa 1993.
8. Collins R, Peto R, Mac Mahon S. Blood pressure, stroke and coronary heart disease: Part 2: Short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context, Lancet 1990; 335: 827-38.
9. Messerli FH, Garavaglia GE, Schmieder RE, et al. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987; 107: 158-61.
10. Pertyński T, Stetkiewicz T. Perimenopauza. W: Diagnostyka i terapia wieku menopauzalnego. Pertyński T (red.). Urban & Partner, Wrocław 2004; 313-22.
11. MacMahon S, Cutler J, Brittain E, et al. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8 (suppl. B): 57-70.
12. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17.
13. Modan M, Or J, Karasik A, et al. Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 1991; 84: 1165-75.
14. Fontbonne A. Insulin: A sex hormone for cardiovascular risk? Circulation 1991; 84: 1442-4.
15. Dembińska-Kieć A. Gospodarka lipidowa po menopauzie. Pol Arch Med Wewn 1998; 100: 211-9.
16. Suzuki M, Ikebuchi M, Shinozaki K, et al. Mechanism and clinical implication of insulin resistance syndrome. Diabetes 1996; 45 (suppl 3): 52-4.
17. Colditz GA, Willett WC, Stampfer FE, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-10.
18. Marrugat JM, Sala J, Masia R, et al. Mortality differences between men and women following first myocardial infarction. JAMA 1998; 280: 1405-9.
19. Sanada H, Midorikawa S, Yatabe J, et al. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker. Hypertens Res 2005; 28: 871-8.
20. Nitenberg A. Hypertension, endothelial dysfunction and cardiovascular risk. Arch Mal Coeur Vaiss 2006; 99: 915-21.
21. Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly; a meta-analysis. Ann Intern Med 1994; 121: 355-62.
22. Van den Hoogen P, van Popele N, Feskens E, et al. Blood pressure and risk of myocardial infarction in elderly men and women: the Rotterdam Study. J Hypertens 1999; 17: 1373-8.
23. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951-7.
24. Prelevic GM, Beljic T. The effect of estrogen and progestogen replacement therapy on systolic flow velosity in healthy postmenopausal women. Maturitas 1994; 29: 37-44.
25. Miller MA, Kerry SM, Cook DG, Cappuccio FP. Cellular adhesion molecules and blood pressure: interaction with sex in a multi-ethnic population. J Hypertens 2004; 22: 705-11.
26. Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 2005; 8 (suppl. 3): 19-27.
27. Nickenig G, Stablein A, Wassmann S, et al. Acute effects of ACE inhibition on coronary endothelial function. J Renin Angiotensin Aldosterone Syst 2000; 1: 361-4.
28. Nicholls MG, Robertson JL. The renin-angiotensin system in the year 2000. J Hum Hypertens 2000; 14: 649-66.
29. Modena MG, Molinari R, Muia N Jr, et al. Double-blind randomized placebo controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women. Am J Hypertens 1999; 12: 1000-8.
30. Mueck AO, Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas 2004; 49: 189-203.
31. Kurtay G, Ozmen B, Erguder I. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus noretisterone acetate on serum NO levels in postmenopausal women. Maturitas 2006; 53: 32-8.
32. Preston R, Alonso A, Panzitta D, et al. Additive effect of drospirenone/ 17beta-estradiol in hypertension in postmenopausal women receiving enalapril. Am J Hypertens 2002; 15: 816-22.
33. Mallareddy M, Hanes V, White WB. Drospirenone, a new progestogen, for postmenopausal women with hypertension. Drugs Aging 2007; 24: 453-66.
34. Nestel PJ, Clinton PM, Noakes M, et al. Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist/hip ratio. J Hypertens 1993; 11: 1387-94.
35. Stajszczyk M, Gmiński J. Ieczenie nadciśnienia u kobiet po menopauzie. Przegl Lek 1997; 54: 789-92.
36. Koch B, Oparil S, Stimpel M. Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women. J Hum Hypertens 1999; 13: 337-42.
37. Suchecka-Rachoń K. Nadciśnienie tetnicze u kobiet. W: Choroby serca u kobiet. Światecka G (red.). Via Medica, Gdańsk 2000; 261-81.